International journal of gynaecology and obstetrics : the official organ of the International Federation of Gynaecology and Obstetrics
-
Int J Gynaecol Obstet · Jul 2021
Meta AnalysisThe effectiveness of the abdominal binder in relieving pain after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials.
Abdominal binder is a non-pharmacological method of relieving pain after surgical procedures. ⋯ The abdominal binder could be an effective, simple, non-pharmacological option of relieving pain and distress after CD.
-
Int J Gynaecol Obstet · Jun 2021
Meta AnalysisTransversus abdominis plane block versus wound infiltration for post-cesarean section analgesia: A systematic review and meta-analysis of randomized controlled trials.
Transversus abdominis plane (TAP) block and wound infiltration (WI) with local anesthetics are used for postoperative analgesia after cesarean section (CS), reducing the need for administration of opioids. ⋯ There might be no significant advantages selecting TAP block over WI for post-CS analgesia.
-
Int J Gynaecol Obstet · Nov 2019
Meta AnalysisA systematic review and meta-analysis of randomized controlled trials comparing 17-alpha-hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth.
Preterm birth causes an increased risk for perinatal morbidity and mortality. ⋯ CDR42017082190.
-
Int J Gynaecol Obstet · Oct 2019
Meta AnalysisA systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries.
Thermal coagulation is gaining popularity for treating cervical intraepithelial neoplasia (CIN) in screening programs in low- and middle-income countries (LMICs) due to unavailability of cryotherapy. ⋯ Both cryotherapy and thermal coagulation are effective treatment modalities for CIN lesions in LMICs.
-
Int J Gynaecol Obstet · Aug 2003
Review Meta AnalysisMisoprostol use during the third stage of labor.
To systematically review the efficacy of misoprostol compared with placebo or other uterotonics in preventing maternal morbidity associated with the third stage of labor. ⋯ Misoprostol was inferior to oxytocin and other uterotonics with regard to any of the third stage of labor outcomes assessed. However, when compared to placebo, misoprostol had a decreased risk of needing additional uterotonics. Thus, in less-developed countries where administration of parenteral uterotonic drugs may be problematic, misoprostol represents a reasonable agent for the management of the third stage of labor. Additional randomized clinical trials examining objective outcome measures (i.e. need for blood transfusion or 10% hemoglobin change) may further define benefits and risks of misoprostol use during the third stage of labor.